Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease

Liver International

Volumn 36, Issue 2, 2016, Pages 268-274

  Hagström, Hannes ^a   Höijer, Jonas ^b   Ludvigsson, Jonas F ^b,c   Bottai, Matteo ^b   Ekbom, Anders ^a   Hultcrantz, Rolf ^a   Stephansson, Olof ^a   Stokkeland, Knut ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d Visby Hospital   (Sweden)

Author keywords

Caesarean section; Epidemiology; Gestational diabetes; Pre eclampsia; Preterm birth; Small for gestational age

Indexed keywords

ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; BODY MASS; CESAREAN SECTION; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PATIENT; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; NONALCOHOLIC FATTY LIVER; OVARY POLYCYSTIC DISEASE; PARITY; PATIENT MONITORING; POISSON DISTRIBUTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; STATISTICAL ANALYSIS; COHORT ANALYSIS; COMPLICATION; DIABETES, GESTATIONAL; NEWBORN; NON-ALCOHOLIC FATTY LIVER DISEASE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; STATISTICS AND NUMERICAL DATA; SWEDEN;

ADULT; CESAREAN SECTION; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; NON-ALCOHOLIC FATTY LIVER DISEASE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; SWEDEN;

EID: 84955452640     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12902     Document Type: Article

References (23)

1. Targher G, Bertolini L, Padovani R, etal. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-8.
2. Marchesini G, Brizi M, Bianchi G, etal. Nonalcoholic fatty liver disease - A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
3. Bellentani S, Saccoccio G, Masutti F, etal. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7.
4. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10: 686-90.
5. Lazo M, Hernaez R, Eberhardt MS, etal. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2013; 178: 38-45.
6. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-85.
7. Baranova A, Tran TP, Birerdinc A, Younossi ZM. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011; 33: 801-14.
8. Mission JF, Marshall NE, Caughey AB. Obesity in pregnancy: a big problem and getting bigger. Obstet Gynecol Surv 2013; 68: 389-99.
9. Sebire NJ, Jolly M, Harris JP, etal. Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-82.
10. Forbes S, Taylor-Robinson SD, Patel N, etal. Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia 2011; 54: 641-7.
11. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-67.
12. Available at http://www.socialstyrelsen.se/register/halsodataregister/medicinskafodelseregistret/inenglish. Accessed: 22 February 2015.
13. Cnattingius S, Ericson A, Gunnarskog J, Kallen B. A quality study of a medical birth registry. Scand J Soc Med 1990; 18: 143-8.
14. Ludvigsson JF, Andersson E, Ekbom A, etal. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
15. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
16. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004; 21: 103-13.
17. Castro LC, Avina RL. Maternal obesity and pregnancy outcomes. Curr Opin Obstet Gynecol 2002; 14: 601-6.
18. Driul L, Cacciaguerra G, Citossi A, etal. Prepregnancy body mass index and adverse pregnancy outcomes. Arch Gynecol Obstet 2008; 278: 23-6.
19. Forbes S, Godsland IF, Taylor-Robinson SD, etal. A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia 2013; 56: 2021-33.
20. Cnattingius S, Villamor E, Johansson S, etal. Maternal obesity and risk of preterm delivery. JAMA 2013; 309: 2362-70.
21. Puri P, Wiest MM, Cheung O, etal. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009; 50: 1827-38.
22. Herrera JA, Arevalo-Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstet Gynecol 1998; 91: 585-90.
23. Noureddin M, Yates KP, Vaughn IA, etal. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 2013; 58: 1644-54.